FEATURE: Companies Continue to Spend Despite Downturn in Markets | GenomeWeb

NEW YORK, March 26 –Applied Biosystems said last week that a drop in demand for its ABI Prism 3700 DNA Analyzers reflected genomics companies’ efforts to rein in spending while they ride out the economic downturn.

But conversations with a number of executives at development-stage genomics companies and consulting firms indicated that spending plans have not changed due to present market conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.